Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL183P (RNA, 7SL, cytoplasmic 183, pseudogene) is annotated as a *pseudogene* corresponding to the functional 7SL RNA gene, which encodes the central RNA component of the signal recognition particle (SRP) involved in cotranslational protein targeting to the endoplasmic reticulum[6][4][5]. Pseudogenes like RN7SL183P are DNA sequences that resemble functional genes but generally lack the capacity to produce functional RNAs or proteins due to disruptive mutations, frameshifts, or the absence of regulatory elements such as promoters[4]. While some pseudogenes are known to influence gene expression or function as long non-coding RNAs, there is currently no evidence that RN7SL183P itself has any direct biological function, therapeutic relevance, or disease involvement[6][4]. It is not considered a therapeutic target and should not be mistaken for the functional 7SL RNA (RN7SL1) gene, which is implicated in various cellular processes and has been studied in the context of cancer biology[1][3]. The listing for RN7SL183P is thus primarily of genomic and evolutionary interest, not as a drug or biomarker target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 183, pseudogene (RN7SL183P).